Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:3697-3706
Published online before print December 5, 2005, doi: 10.1161/CIRCULATIONAHA.105.575332
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/24/3697    most recent
CIRCULATIONAHA.105.575332v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dobrev, D.
Right arrow Articles by Ravens, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dobrev, D.
Right arrow Articles by Ravens, U.
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport

(Circulation. 2005;112:3697-3706.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation

D. Dobrev, MD; A. Friedrich, CandMed; N. Voigt, CandMed; N. Jost, PhD; E. Wettwer, PhD; T. Christ, MD; M. Knaut, MD; U. Ravens, MD

From the Department of Pharmacology and Toxicology (D.D., A.F., N.V., E.W., T.C., U.R.) and Cardiovascular Center (M.K.), Medical Faculty, Dresden University of Technology, Dresden, Germany; and Department of Pharmacology and Pharmacotherapy (N.J.), Medical University of Szeged, Szeged, Hungary.

Correspondence to Dr Dobromir Dobrev, Department of Pharmacology and Toxicology, Dresden University of Technology, Fetscherstrasse 74, 01307 Dresden, Germany. E-mail dobrev{at}rcs.urz.tu-dresden.de

Received July 14, 2005; revision received September 22, 2005; accepted October 7, 2005.

Background— The molecular mechanism of increased background inward rectifier current (IK1) in atrial fibrillation (AF) is not fully understood. We tested whether constitutively active acetylcholine (ACh)-activated IK,ACh contributes to enhanced basal conductance in chronic AF (cAF).

Methods and Results— Whole-cell and single-channel currents were measured with standard voltage-clamp techniques in atrial myocytes from patients with sinus rhythm (SR) and cAF. The selective IK,ACh blocker tertiapin was used for inhibition of IK,ACh. Whole-cell basal current was larger in cAF than in SR, whereas carbachol (CCh)-activated IK,ACh was lower in cAF than in SR. Tertiapin (0.1 to 100 nmol/L) reduced IK,ACh in a concentration-dependent manner with greater potency in cAF than in SR (–logIC50: 9.1 versus 8.2; P<0.05). Basal current contained a tertiapin-sensitive component that was larger in cAF than in SR (tertiapin [10 nmol/L]-sensitive current at –100 mV: cAF, –6.7±1.2 pA/pF, n=16/5 [myocytes/patients] versus SR, –1.7±0.5 pA/pF, n=24/8), suggesting contribution of constitutively active IK,ACh to basal current. In single-channel recordings, constitutively active IK,ACh was prominent in cAF but not in SR (channel open probability: cAF, 5.4±0.7%, n=19/9 versus SR, 0.1±0.05%, n=16/9; P<0.05). Moreover, IK1 channel open probability was higher in cAF than in SR (13.4±0.4%, n=19/9 versus 11.4±0.7%, n=16/9; P<0.05) without changes in other channel characteristics.

Conclusions— Our results demonstrate that larger basal inward rectifier K+ current in cAF consists of increased IK1 activity and constitutively active IK,ACh. Blockade of IK,ACh may represent a new therapeutic target in AF.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
EuropaceHome page
K. Nishida, G. Michael, D. Dobrev, and S. Nattel
Animal models for atrial fibrillation: clinical insights and scientific opportunities
Europace, October 29, 2009; (2009) eup328v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Patel, G.-X. Yan, and P. R. Kowey
Dronedarone
Circulation, August 18, 2009; 120(7): 636 - 644.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-H. Yeh, B. Burstein, X. Y. Qi, M. Sakabe, D. Chartier, P. Comtois, Z. Wang, C.-T. Kuo, and S. Nattel
Funny Current Downregulation and Sinus Node Dysfunction Associated With Atrial Tachyarrhythmia: A Molecular Basis for Tachycardia-Bradycardia Syndrome
Circulation, March 31, 2009; 119(12): 1576 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, and S. Nattel
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis
Cardiovasc Res, February 15, 2009; 81(3): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
U. Ravens and E. Cerbai
Role of potassium currents in cardiac arrhythmias
Europace, October 1, 2008; 10(10): 1133 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. V. Postma, J. B.A. van de Meerakker, I. B. Mathijssen, P. Barnett, V. M. Christoffels, A. Ilgun, J. Lam, A. A.M. Wilde, R. H. Lekanne Deprez, and A. F.M. Moorman
A Gain-of-Function TBX5 Mutation Is Associated With Atypical Holt-Oram Syndrome and Paroxysmal Atrial Fibrillation
Circ. Res., June 6, 2008; 102(11): 1433 - 1442.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. Savelieva and J. Camm
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
Europace, June 1, 2008; 10(6): 647 - 665.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Dobrev and E. Wettwer
Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis
Cardiovasc Res, June 1, 2008; 78(3): 411 - 412.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
S. Nattel, B. Burstein, and D. Dobrev
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 62 - 73.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. R. Ehrlich, P. Biliczki, S. H. Hohnloser, and S. Nattel
Atrial-Selective Approaches for the Treatment of Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Voigt, A. Maguy, Y.-H. Yeh, X. Qi, U. Ravens, D. Dobrev, and S. Nattel
Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes
Cardiovasc Res, January 1, 2008; 77(1): 35 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Mintert, L. I. Bosche, A. Rinne, M. Timpert, M.-C. Kienitz, L. Pott, and K. Bender
Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4
J. Physiol., November 15, 2007; 585(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. R. Stanfield
Homomers of Kir.3.4 in atrial myocytes: their relevance to atrial fibrillation
J. Physiol., November 15, 2007; 585(1): 1 - 1.
[Full Text] [PDF]


Home page
EuropaceHome page
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace, June 1, 2007; 9(6): 335 - 379.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-H. Yeh, J. R. Ehrlich, X. Qi, T. E. Hebert, D. Chartier, and S. Nattel
Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes
Cardiovasc Res, June 1, 2007; 74(3): 406 - 415.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Voigt, A. Friedrich, M. Bock, E. Wettwer, T. Christ, M. Knaut, R. H. Strasser, U. Ravens, and D. Dobrev
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation
Cardiovasc Res, June 1, 2007; 74(3): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Fu, X. Huang, L. Piao, A. N. Lopatin, and R. R. Neubig
Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2532 - H2539.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Arora, J. Ng, J. Ulphani, I. Mylonas, H. Subacius, G. Shade, D. Gordon, A. Morris, X. He, Y. Lu, et al.
Unique Autonomic Profile of the Pulmonary Veins and Posterior Left Atrium
J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1340 - 1348.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. C.M. Choisy, L. A. Arberry, J. C. Hancox, and A. F. James
Increased Susceptibility to Atrial Tachyarrhythmia in Spontaneously Hypertensive Rat Hearts
Hypertension, March 1, 2007; 49(3): 498 - 505.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. de Haan, M. Greiser, E. Harks, Y. Blaauw, A. van Hunnik, S. Verheule, M. Allessie, and U. Schotten
AVE0118, Blocker of the Transient Outward Current (Ito) and Ultrarapid Delayed Rectifier Current (IKur), Fully Restores Atrial Contractility After Cardioversion of Atrial Fibrillation in the Goat
Circulation, September 19, 2006; 114(12): 1234 - 1242.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Fatini, E. Sticchi, M. Genuardi, F. Sofi, F. Gensini, A. M. Gori, M. Lenti, A. Michelucci, R. Abbate, and G. F. Gensini
Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation
Eur. Heart J., July 2, 2006; 27(14): 1712 - 1718.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T.-J. Cha, J. R. Ehrlich, D. Chartier, X.-Y. Qi, L. Xiao, and S. Nattel
Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias
Circulation, April 11, 2006; 113(14): 1730 - 1737.
[Abstract] [Full Text] [PDF]